Dr Paras Karmacharya discusses the findings of the PsA Research Consortium (PARC) cohort study that underscores the need for personalized treatment approaches in psoriatic arthritis, accounting for unique disease features.
Dr Paras Karmacharya discusses the findings of the PsA Research Consortium (PARC) cohort study that underscores the need for personalized treatment approaches in psoriatic arthritis, accounting for unique disease features.
A recent study found no significant difference in the risk of cardiovascular events among rheumatoid arthritis patients treated with Janus kinase inhibitors or biologic disease-modifying drugs.
A recent study found no significant difference in the risk of cardiovascular events among rheumatoid arthritis patients treated with Janus kinase inhibitors or biologic disease-modifying drugs.
Researchers recently conducted a study to understand the impact of obesity on disease activity for ankylosing spondylitis. Did they find a connection? Take our quiz to find out!
Researchers recently conducted a study to understand the impact of obesity on disease activity for ankylosing spondylitis. Did they find a connection? Take our quiz to find out!
The Psoriasis Epidemiology Screening Tool (PEST) can help identify patients with psoriasis at higher risk of developing psoriatic arthritis. Do you know the key indicator? Take our quiz to find out!
The Psoriasis Epidemiology Screening Tool (PEST) can help identify patients with psoriasis at higher risk of developing psoriatic arthritis. Do you know the key indicator? Take our quiz to find out!